Program At a Glance Non-Surgical Medical Weight Loss Program The Program Treatment Type Non-surgical, physician-directed medical weight loss program Medication Semaglutide, a GLP-1 receptor agonist that reduces appetite, increases satiety, and slows gastric emptying to support sustained weight loss Administration Self-administered subcutaneous injection at home according to an individualized treatment plan Program Structure Comprehensive physician-supervised program including medical evaluation, metabolic assessment, medication management, lifestyle coaching, and ongoing clinical follow-up Candidacy Determined through comprehensive consultation and medical screening
GLP-1R is a G protein-coupled receptor, or GPCR, that has been widely studied because receptor activation connects extracellular peptide signaling with intracellular pathways such as cyclic AMP generation, protein kinase A signaling, receptor internalization, and downstream transcriptional responses
[DOI] [PubMed] [Google Scholar] 165.De Brito B.B., Da Silva F.A.F., Soares A.S., Pereira V.A., Santos M.L.C., Sampaio M.M., Neves P.H.M., De Melo F.F
2024 Jul 3.Klein SR, Hobai IA
Once approved, youll receive weekly injections and ongoing support from our team to help you succeed
